Status:
TERMINATED
Treatment of Resectable Malignant Brain Tumors
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Brain Tumor
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The goals of this study are to evaluate each of the following items: 1. Time to recurrence in patients receiving brachytherapy with the GliaSite RTS 2. Overall survival (OS) in patients with malignan...
Detailed Description
Your doctor has found that you have a brain tumor that needs to be surgically removed. Your doctor has explained the risks and benefits of the surgery. After the brain tumor is surgically removed, som...
Eligibility Criteria
Inclusion
- Patient must have histologically proven malignant brain tumor
- Patient must be a candidate for surgical resection of the tumor mass.
- Patient must not be pregnant or breast-feeding. All patients with the potential for pregnancy should be counseled and requested to follow acceptable birth control methods to avoid conception.
- Patient must sign informed consent form
Exclusion
- 1\. Serious concurrent infection or medical illness which could jeopardize the ability of the patient to receive the GliaSite catheter with reasonable safety.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00415467
Start Date
January 1 2005
End Date
July 1 2008
Last Update
August 2 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
U.T.M.D. Anderson Cancer Center
Houston, Texas, United States, 77030